IRIS
Patti, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.075
NA - Nord America 3.134
AS - Asia 516
SA - Sud America 15
OC - Oceania 7
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.108
IE - Irlanda 2.312
UA - Ucraina 639
SE - Svezia 458
IT - Italia 411
CN - Cina 202
HK - Hong Kong 199
DE - Germania 149
FR - Francia 39
IN - India 36
IR - Iran 31
CA - Canada 26
BE - Belgio 13
FI - Finlandia 10
NL - Olanda 10
GB - Regno Unito 9
PK - Pakistan 8
AU - Australia 7
KR - Corea 7
MY - Malesia 7
RU - Federazione Russa 6
JP - Giappone 5
VN - Vietnam 5
BR - Brasile 4
CH - Svizzera 4
MO - Macao, regione amministrativa speciale della Cina 4
PH - Filippine 4
TH - Thailandia 4
CL - Cile 3
GR - Grecia 3
PE - Perù 3
VE - Venezuela 3
AR - Argentina 2
EU - Europa 2
LI - Liechtenstein 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
SG - Singapore 2
TR - Turchia 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
KE - Kenya 1
MK - Macedonia 1
NO - Norvegia 1
SN - Senegal 1
Totale 7.752
Salva come PNG Salva come JPEG
Città #
Dublin 2.268
Jacksonville 1.250
Lawrence 281
Princeton 281
Wilmington 279
Hong Kong 188
Beijing 173
Ashburn 105
Chandler 82
San Mateo 62
Ann Arbor 55
Bremen 48
Milan 40
Piemonte 38
Mülheim 32
Novara 31
Norwalk 26
Houston 24
Turin 22
Fairfield 21
Vercelli 21
Torino 20
West Jordan 20
Menlo Park 15
Andover 14
Brussels 13
Woodbridge 13
Toronto 12
Chennai 11
Monmouth Junction 11
Ardabil 9
Helsinki 9
Zanjan 9
Boardman 8
Des Moines 8
Lancenigo-Villorba 8
Montreal 8
Nanjing 8
Rome 7
Seattle 7
Sham Shui Po 7
Eindhoven 6
New York 6
Philadelphia 6
Strasbourg 6
Sydney 6
Alessandria 5
Augusta 5
Cassano Magnago 5
Frankfurt am Main 5
Grafing 5
Naples 5
Palermo 5
Paris 5
Amsterdam 4
Hefei 4
Macao 4
Munich 4
Odalengo Grande 4
Oleggio 4
Redwood City 4
Senigallia 4
Shanghai 4
Tehran 4
Athens 3
Bad Homburg 3
Bangalore 3
Bangkok 3
Berlin 3
Bien Hoa 3
Binasco 3
Busanjin-gu 3
Cambridge 3
Fremont 3
Garden City 3
Goyang-si 3
Guangzhou 3
Ipoh 3
Leawood 3
Lima 3
Mumbai 3
Pioltello 3
Pune 3
Rennes 3
Santa Clara 3
Sialkot 3
St Petersburg 3
Temuco 3
Valencia 3
Vancouver 3
Villa Cortese 3
Albenga 2
Appiano Gentile 2
Bagnoli del Trigno 2
Bari 2
Berbenno Di Valtellina 2
Biella 2
Bollate 2
Bucharest 2
Buffalo 2
Totale 5.753
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 192
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 137
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 94
Change over time of COVID-19 hospital presentation in Northern Italy 89
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 87
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 68
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 63
One-Year Follow up of Noninvasive Respiratory Support in General Wards 62
ANMCO/SICI-GISE paper on antiplatelet therapy in acute coronary syndrome 61
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 55
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 51
Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases 46
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 46
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 44
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 43
Metabolomics diagnosis of covid-19 from exhaled breath condensate 41
Safety and efficacy of selective, clopidogrel-based strategies in acute coronary syndrome: a study-level meta-analysis 40
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 39
Safety and Efficacy of Different Antithrombotic Strategies After Transcatheter Aortic Valve Implantation: A Network Meta-Analysis 39
Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention 39
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease 38
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 38
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 38
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 37
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 36
Percutaneous coronary interventions and statin therapy 36
Clinical benefits of statin pretreatment in patients undergoing coronary revascularization 36
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 36
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 35
Causes of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: findings from the SYNCOPACED registry 35
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 35
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 35
Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study 34
Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome 34
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 34
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 34
Are we ready for a gender-specific approach in interventional cardiology? 33
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 33
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 33
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 33
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 32
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 32
Apoptosis in recent myocardial infarction 32
Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak 32
A clinical-in silico study on the effectiveness of multipoint bicathodic and cathodic-anodal pacing in cardiac resynchronization therapy 32
Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease 31
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 31
Atorvastatin for reduction of myocardial damage during angioplasty trials 31
Chapter "Chronobiology of the haemostatic system", for the book “Physiology and pharmacology of biological rhythms” (Editors P. H. Redfern e B. Lemmer) (Springer) 31
Infective endocarditis complicating COVID-19 pneumonia: a case report 31
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry 31
Prevention of ischaemic events in subjects with polydistrict vascular disease 31
Usefulness of a multiparametric evaluation including global longitudinal strain for an early diagnosis of acute myocarditis 31
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 30
Association of virulent Helicobacter pylori strains with ischemic heart disease 30
Myocardial infarction during pregnancy and postpartum: A review 30
Monacolin Product Monograph (Springer Healthcare) 30
Risk of syncopal recurrences in patients treated with permanent pacing for bradyarrhythmic syncope: Role of correlation between symptoms and electrocardiogram findings 30
Terapie antitrombotiche in pazienti con infezione da SARS-CoV-2: Dalle attuali evidenze alle ragionevoli raccomandazioni – Position paper del gruppo di studio aterosclerosi, trombosi e biologia vascolare 30
Statin loading for acute coronary syndromes 29
Influence of Platelet Reactivity on Outcome of Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty 29
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 29
Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention - Results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study 29
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 29
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 29
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 29
Uric acid and contrast-induced nephropathy: An updated review and meta-regression analysis 29
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 29
Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak 29
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 29
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in northern Italy 29
Clustering of blood cell count abnormalities and future risk of death 29
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study * 29
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 28
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 28
Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment 28
Percutaneous closure of a pulmonary arteriovenous malformation in young patient with cryptogenic stroke 28
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 28
Transapical closure of paraprosthetic mitral leak in a patient with inferior vena cava interruption and azygos continuation 28
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 28
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 28
Primum non nocere does not justify clinical inertia for stroke prevention in elderly patients with atrial fibrillation in the era of direct oral anticoagulants 28
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 28
Point-of-Care Assessment of Platelet Reactivity After Clopidogrel to Predict Myonecrosis in Patients Undergoing Percutaneous Coronary Intervention 28
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 28
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study 28
[Zero-fluoroscopy transcatheter ablation and CRT-D implantation: new frontiers of electroanatomical mapping systems] 27
Endothelial Dysfunction, Fibrinolytic Activity, and Coagulation Activity in Patients With Atrial Fibrillation According to Type II Diabetes Mellitus Status 27
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 27
Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery - Results of the ARMYDA-3 (Atorvastatin for reduction of MYocardial dysrhythmia after cardiac surgery) study 27
Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass 27
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study) 27
Comparison of Safety and Efficacy of Bivalirudin Versus Unfractionated Heparin in High-Risk Patients Undergoing Percutaneous Coronary Intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin Study) 27
Impaired flow-mediated dilation and risk of restenosis in patients undergoing coronary stent implantation 27
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 27
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 27
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 27
Apoptosis and post-infarction left ventricular remodeling 27
Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study) 27
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 27
Totale 3.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.905
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.905
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/20201.051 0 0 2 0 2 10 437 10 203 178 209 0
2020/20211.686 197 0 197 2 212 29 477 15 247 31 264 15
2021/20221.266 56 34 64 91 72 22 43 49 147 72 242 374
2022/20233.291 327 108 144 30 93 127 79 98 2.083 22 133 47
2023/20241.074 78 79 80 45 307 38 217 63 68 77 22 0
Totale 8.376